Digital Edition

Ophthalmology Times: February 1, 2021
Volume: 46
Issue: 2

Ophthalmology Times: January 2021
Volume: 46
Issue: 1

Ophthalmology Times: December 2020
Volume: 45
Issue: 20

Ophthalmology Times: November 15, 2020
Volume: 45
Issue: 19

Ophthalmology Times: November 1, 2020
Volume: 45
Issue: 18

Ophthalmology Times: October 15, 2020
Volume: 45
Issue: 17

Ophthalmology Times: October 1, 2020
Volume: 45
Issue: 16

Ophthalmology Times: September 15, 2020
Volume: 45
Issue: 15

Ophthalmology Times: September 1, 2020
Volume: 45
Issue: 14

Ophthalmology Times: August 2020
Volume: 45
Issue: 13

Ophthalmology Times: July 15, 2020
Volume: 45
Issue: 12

Ophthalmology Times: July 1, 2020
Volume: 45
Issue: 11

Ophthalmology Times: June 1, 2020
Volume: 45
Issue: 9

Ophthalmology Times: June 15, 2020
Volume: 45
Issue: 10

Ophthalmology Times: May 2020
Volume: 45
Issue: 8

Ophthalmology Times: April 15, 2020
Volume: 45
Issue: 7

Ophthalmology Times: April 1, 2020
Volume: 45
Issue: 6

Ophthalmology Times: March 15, 2020
Volume: 45
Issue: 5

Ophthalmology Times: March 1, 2020
Volume: 45
Issue: 4

Ophthalmology Times: Feb. 15, 2020
Volume: 45
Issue: 3

Ophthalmology Times: Feb. 1, 2020
Volume: 45
Issue: 2

Ophthalmology Times: January 2020
Volume: 45
Issue: 1

Ophthalmology Times: December 2019
Volume: 44
Issue: 20

Ophthalmology Times: Nov. 15, 2019
Volume: 44
Issue: 19

Ophthalmology Times: Nov. 1, 2019
Volume: 44
Issue: 18

Vol. 44 No. 17
Volume: 44
Issue: 17

Vol. 44 No. 16
Volume: 44
Issue: 16

Vol. 44 No. 15
Volume: 14
Issue: 15

Vol. 44 No. 14
Volume: 44
Issue: 14

Ophthalmology Times, July 1 2019
Volume: 44
Issue: 11
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
3
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
4
PainReform launches development plan for OcuRing-K, readies phase 2 trial
5



.png)


